Navigation Links
Esphera3 International Founded on 'Patient Focused Care'

KALAMAZOO, Mich., Feb. 19 /PRNewswire/ -- Esphera3 International (E3I) is a broad based Integrated Healthcare Group founded on the principles of "Patient Focused Care." Currently engaged in multiple projects around the world, E3I encompasses all aspects of a partnered care health approach including operational transformation to optimize the design, resource management and financial operations of healthcare.

E3I and its channel partners enjoy a combined total of a 25-year relationship with Stryker Corporation along with 25 years experience planning, building, and developing healthcare facilities and maximizing operations. E3I has emerged as a global development business with the strength of its channel partners in banking, investment, real estate, management operations, and training.

According to Tom Fullan, a consultant to E3I and the Stryker Corporation, "Partnered Care Health, Operational Optimization and MySim2Learn are the focus areas that demonstrate an enduring legacy in assisting doctors, nurses, and allied health workers in the quest to raise the quality bar in healthcare. E3I has been developed to work collaboratively with Stryker Corporate Clients worldwide and to focus on quality delivery and patient safety."

Esphera3 International launched an expanded, redesigned website on February 19, 2009 at There you will find the broad base of capabilities comprised of Education, Operations Optimization and Infrastructure.

For more information on E3I contact Tom Fullan, (877) 269-0788 or visit

About E3I

Esphera3 International (E3I) is an entity that balances healthcare facility design, construction, and development owned by M.W. Vander Veen Company (development), Eckert Wordell (medical planning, design and equipment), and CSM Group (construction) all from Kalamazoo, Michigan.

E3I enjoys a cumulative 25-year relationship with Stryker Corporation and also 25 years of experience planning, building, and developing healthcare facilities in the United States and Canada. For more information on E3I, visit .

About Stryker

Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives and to reduce healthcare costs. The company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. For more information on Stryker, visit

SOURCE Esphera3 International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Valensa Internationals Dr. Rudi E. Moerck Appointed CEO
2. Osteotech Receives 13485:2003 ISO Certification; Company Meets International Standards for Medical Device Manufacturing
3. IOF joins ECCEO9 at leading international meeting in Athens
4. The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.
5. HUYA Bioscience International Announces Collaboration Agreement With the Beijing Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College
6. China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results
7. International Humanization of Birth Conference
8. Natural Alternatives International, Inc. Announces Fiscal 2009 Q2 Results
9. WaterHealth International Announces $15 Million Financing by IFC
10. i.HUG Foundation Receives International Grant: Hires a School Nurse to Improve Student Health and Learning
11. Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... "When I underwent ... bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In order to ... the patent-pending RECOVERY BRA for added comfort and support. The bra is easier ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bcureful—a non-profit organization devoted to ... raising public awareness of the disorder while helping to bring expert medical care ... to bolster progress at the Tuberous Sclerosis Complex Center at Ann & Robert ...
(Date:11/24/2015)... Florida (PRWEB) , ... November 25, 2015 , ... ... planning and monitoring. Their Care Plan software creates an agreement between the ... patient care plan, including financial, scheduling, monitoring, notification, and projections. Click ...
(Date:11/24/2015)... ... November 24, 2015 , ... Young patients with a ... Dr. Angela Wolfman and Dr. Kedar S. Lele, who are pediatric dentists in ... and fillings, the WaterLase iPlus 2.0™ system causes minimal discomfort and bleeding to the ...
(Date:11/24/2015)... ... November 25, 2015 , ... ... solutions for drugs, biologics, consumer health and global clinical supply services, today announced ... upcoming Clinical Trial Supply East Asia Conference, to be held at the InterContinental ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Nov. 24, 2015  Thanks to a donor with ... Mary,s Medical Center,s Sister Diane Grassilli Center for Women,s ... in San Francisco . ... stepped forward with a gift of $617,320 that allowed ... Mammography with Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional ...
(Date:11/24/2015)... 24, 2015  Array BioPharma Inc. (Nasdaq: ... Officer, Ron Squarer , will present at ... York.  The public is welcome to participate in ... BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  , Ron ... 2015Time:1:30 p.m. Eastern Time Webcast: , ...
(Date:11/24/2015)... and VANCOUVER, Nov. 24, 2015 /PRNewswire/ - ESSA ... EPIX ) announced today that the first patient ... of EPI-506 as a treatment for metastatic castration-resistant prostate ... and Canada.  --> the ... In the Phase 1/2 clinical trial, ESSA intends ...
Breaking Medicine Technology: